Literature DB >> 24141572

Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis.

Japarath Prechapanich1, Takeshi Kajihara, Keiko Fujita, Kazuko Sato, Satomi Uchino, Kayoko Tanaka, Sachiko Matsumoto, Masumi Akita, Masabumi Nagashima, Jan J Brosens, Osamu Ishihara.   

Abstract

The pathogenesis of endometriosis remains poorly understood at least in part because early stages of the disease process are difficult to investigate. Previous studies have proposed a three-dimensional fibrin matrix culture model to study human endometriosis. We examined the ultrastructural features of the endometriosis in this model and assessed the effect of a progestin on endometrial outgrowth and apoptosis in this culture system. Endometrial explants were placed in three-dimensional fibrin matrix culture and treated with and without various concentrations of the progestin dienogest. By the second week, endometrial gland-like formation was established in outgrowths both attached to and at a distance from the explants. These cells formed a combination of clumps and tubular monolayers surrounding a central cavity. Electron microscopy demonstrated that these cells are polarized with microvilli on the apical surface, desmosome-like structures, and basement membrane; features consistent with glandular epithelial cells. Outgrowth of endometrial stromal cells and glandular formation was impaired in response to dienogest in a dose-dependent manner. Our study shows that the human endometrial explants cultured in three-dimensional fibrin matrix establish outgrowths that ultrastructurally resemble ectopic endometrial implants. This model may provide insight into the cellular processes leading to endometriosis formation and enables screening of therapeutic compounds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141572     DOI: 10.1007/s00795-013-0059-3

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  32 in total

1.  The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.

Authors:  H Okada; T Nakajima; T Yoshimura; K Yasuda; H Kanzaki
Journal:  Mol Hum Reprod       Date:  2001-04       Impact factor: 4.025

2.  Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys.

Authors:  S Sasagawa; Y Shimizu; T Nagaoka; H Tokado; K Imada; K Mizuguchi
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

3.  Isolating and maintaining highly polarized primary epithelial cells from normal human duodenum for growth as spheroid-like vesicles.

Authors:  H J Boxberger; T F Meyer; M C Grausam; K Reich; H D Becker; M J Sessler
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

4.  Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain.

Authors:  Maria Elisabetta Coccia; Francesca Rizzello; Antonio Palagiano; Gianfranco Scarselli
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-04-09       Impact factor: 2.435

5.  Ultrastructural comparison of endometriotic implants and eutopic endometrium.

Authors:  K W Schweppe; R M Wynn; F K Beller
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

6.  Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.

Authors:  Kaoruko Yamanaka; Bing Xu; Izumi Suganuma; Izumi Kusuki; Shizuka Mita; Yutaka Shimizu; Kiyoshi Mizuguchi; Jo Kitawaki
Journal:  Fertil Steril       Date:  2011-11-30       Impact factor: 7.329

7.  Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.

Authors:  Dong-Yun Lee; Duk-Soo Bae; Byung-Koo Yoon; DooSeok Choi
Journal:  Hum Reprod       Date:  2010-10-11       Impact factor: 6.918

8.  An in vitro model to study the pathogenesis of the early endometriosis lesion.

Authors:  Craig A Witz; Herve Dechaud; Iris A Montoya-Rodriguez; Mika R Thomas; Anitha S Nair; Victoria E Centonze; Robert S Schenken
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

9.  DNA fragmentation, DNA repair and apoptosis induced in primary rat hepatocytes by dienogest, dydrogesterone and 1,4,6-androstatriene-17beta-ol-3-one acetate.

Authors:  Francesca Mattioli; Claudia Garbero; Marzia Gosmar; Valeria Manfredi; Roberto Carrozzino; Antonietta Martelli; Giovanni Brambilla
Journal:  Mutat Res       Date:  2004-11-14       Impact factor: 2.433

10.  Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms.

Authors:  S K Banu; J Lee; V O Speights; A Starzinski-Powitz; J A Arosh
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

View more
  3 in total

Review 1.  Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.

Authors:  Giovanni Grandi; Michael Mueller; Nick A Bersinger; Angelo Cagnacci; Annibale Volpe; Brett McKinnon
Journal:  Inflamm Res       Date:  2015-12-09       Impact factor: 4.575

Review 2.  Strategies for modelling endometrial diseases.

Authors:  Alina R Murphy; Hannes Campo; J Julie Kim
Journal:  Nat Rev Endocrinol       Date:  2022-09-01       Impact factor: 47.564

Review 3.  In-vitro models of human endometriosis.

Authors:  Hongjie Fan
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.